List
The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.
-
Lactate Sensors for Continuous Physiological Monitoring
SBC: PROFUSA, INC. Topic: SB12A003The overall goal of the Phase II work is to advance novel tissue-integrating lactate sensors towards human testing as rapidly as possible (proposal does not include human testing itself). A single sensor injected subcutaneously can provide months of continuous physiological monitoring data transmitted wirelessly through near-infrared light for remote monitoring.This proposal includes activities su ...
SBIR Phase II 2018 Department of DefenseDefense Advanced Research Projects Agency -
Enhancing Situational Awareness to Counter Swarming and Other Nonlinear, Dispersed Tactics Against Naval Surface Forces
SBC: SYSTEMS & TECHNOLOGY RESEARCH LLC Topic: N122117The Advanced Electronic Development Program (AEDP) will develop prototypes of photonic and digital components. Under AEDP, electronic equipment will be developed and prototyped, with components integrated for a capability demonstration. This work will be performed underthe Phase II SBIR program.
SBIR Phase II 2018 Department of DefenseDefense Advanced Research Projects Agency -
Serum Hepcidin Immunoassay: Laboratory to Marketplace
SBC: INTRINSIC LIFESCIENCES LLC Topic: NIDDKDESCRIPTION (provided by applicant): Disorders of iron metabolism are among the most common human diseases. During the last decade, rapid progress has been made in understanding the molecular basis of iron homeostasis and its disorders. The peptide hormonehepcidin has emerged as the master regulator of iron metabolism. Dysregulation of hepcidin is the principal or contributing factor in most syste ...
SBIR Phase II 2014 Department of Health and Human Services -
Serum Hepcidin Immunoassay: Laboratory to Marketplace
SBC: INTRINSIC LIFESCIENCES LLC Topic: 300DESCRIPTION provided by applicant Disorders of iron metabolism are among the most common human diseases During the last decade rapid progress has been made in understanding the molecular basis of iron homeostasis and its disorders The peptide hormone hepcidin has emerged as the master regulator of iron metabolism Dysregulation of hepcidin is the principal or contributing factor in most syst ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Rapid point of care test for Lyme serodiagnosis based on novel ultra sensitive de
SBC: IMMUNETICS, INC. Topic: NIAIDDESCRIPTION provided by applicant Lyme disease is the most prevalent vector borne disease in the U S with about cases per year reported by CDC and a range now covering states Early diagnosis and treatment of Lyme disease is important to prevent the disease from progressing to a systemic infection characterized by chronic arthritis carditis or neurological disorders Where a patien ...
SBIR Phase II 2014 Department of Health and Human Services -
Rapid, disposable, nucleic acid diagnostic device for multiplexed point of care f
SBC: MESA TECH INTERNATIONAL, INC. Topic: NIAIDDESCRIPTION provided by applicant Rapid and accurate identification of highly infectious and pathogenic disease is extremely important for the early forecast of outbreak risk and the effective deployment of medical and administrative countermeasures Unfortunately current diagnostics for use at the point of care POC are largely immunological assays that often lack adequate sensitivity speci ...
SBIR Phase II 2014 Department of Health and Human Services -
"LAPPD Commercialization Fully Integrated Sealed Detector Devices
SBC: INCOM, INC. Topic: 38aThe high energy physics (HEP) community, the scientific and medical communities and the public at large, require the availability of high sensitivity photo- sensors with improved spatial and temporal resolution that can be scaled to large areas, and manufactured in a robust, durable, and compact package at a low cost. Phase I successfully demonstrated the underlying enabling scientific and techni ...
SBIR Phase II 2014 Department of Energy -
An Immunoprotectant for Marburg Virus
SBC: MAPP BIOPHARMACEUTICAL, INC. Topic: RDESCRIPTION provided by applicant Mortality rates associated with Marburg virus MARV outbreaks range from to over MARV is included by the Centers for Disease Control and Prevention as among the Category A agents or andquot high priority agents that pose a risk to national security andquot MARV not only causes acute and terrifying disease but it is relatively stable in wet or ...
SBIR Phase II 2014 Department of Health and Human Services -
Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials
SBC: Biomedical Research Models, Inc. Topic: NIAIDDESCRIPTION (provided by applicant): Globally, an estimated 16.2% of the human population is infected with HSV-2 including gt17% of the U.S. adult population. Genital herpes is associated with an increased risk of HIV acquisition and transmission and HSV-2infection can cause neonatal herpes with high infant mortality. HSV-2 infection in the adult population has increased substantially in the past ...
SBIR Phase II 2014 Department of Health and Human Services -
Advancing a Mucosal HSV-2 Vaccine Towards Clinical Trials
SBC: Biomedical Research Models, Inc. Topic: RDESCRIPTION provided by applicant Globally an estimated of the human population is infected with HSV including andgt of the U S adult population Genital herpes is associated with an increased risk of HIV acquisition and transmission and HSV infection can cause neonatal herpes with high infant mortality HSV infection in the adult population has increased substantially in the ...
SBIR Phase II 2014 Department of Health and Human Services